Head-to-head · WeighScore
Ozari Health vs PlexusDx
The verdict
Ozari Health takes it — 69.8/100 to 67.7/100.
Ozari Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ozari Health is a telehealth weight-loss platform offering physician-prescribed compounded GLP-1 from licensed pharmacies — semaglutide from $86/month and tirzepatide from around $149/month, with shipping…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ozari Health | PlexusDx |
|---|---|---|
| WeighScore | 69.8/100 | 67.7/100 |
| Grade | C | C |
| Scorecard rank | #120 | #162 |
| Semaglutide | $86/mo (compounded) | $149/mo (starting dose, compounded) |
| Tirzepatide | $149/mo (compounded) | $249/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #120 · C
Strengths
- Very low entry pricing — compounded semaglutide from $86/month
- LegitScript certified and operated by a named entity (Ozari LLC)
- Board-certified physicians; meds compounded in 503A and 503B facilities
- Shipping included in the plan price
Where it loses points
- Doesn't clearly list which states it serves or name its pharmacies
- Tirzepatide and higher semaglutide doses cost more than the $86 headline
- Compounded semaglutide and tirzepatide only — no brand-name options
- Newer, lighter web presence than established competitors
Graded #162 · C
Strengths
- Licensed providers available in all 50 states
- Range of options including low-cost microdose GLP-1 from $129/mo
- Optional Precision Peptide genetic panel adds a personalization angle
- Independent clinician review via state-licensed telehealth platform
- Compounded medications from state-licensed pharmacies
Where it loses points
- Compounded medications only; no FDA-approved brand options
- Specific compounding pharmacies not named
- Genetic-panel upsell may not add clinical value for everyone
- Tirzepatide pricing from $249/mo is higher than budget rivals
- No insurance accepted
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.